Deep Learning Allows Automated Analysis of Cystogenesis in Novel Xenopus Animal Models for Autosomal Polycystic Kidney Disease

被引：0
|
作者：
Naert, Thomas [1 ]
Lienkamp, Soeren S. [1 ]
机构：
[1] Univ Zurich, Zurich, Switzerland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO269
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [31] Novel Treatments of Autosomal Dominant Polycystic Kidney Disease
    Mahnensmith, Rex L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (05): : 831 - 836
  • [32] A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2
    Torra, R
    Badenas, C
    San Millán, JL
    Pérez-Oller, L
    Estivill, X
    Darnell, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) : 345 - 352
  • [33] Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease
    Lu, Yi
    Sun, Yongzhan
    Liu, Zhiheng
    Lu, Yumei
    Zhu, Xu
    Lan, Bingxue
    Mi, Zeyun
    Dang, Lin
    Li, Na
    Zhan, Wenlei
    Tan, Lu
    Pi, Jingbo
    Xiong, Hui
    Zhang, Lirong
    Chen, Yupeng
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (554)
  • [34] Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease
    Mi, Zeyun
    Song, Yandong
    Cao, Xinyi
    Lu, Yi
    Liu, Zhiheng
    Zhu, Xu
    Geng, Meijuan
    Sun, Yongzhan
    Lan, Bingxue
    He, Chaoran
    Xiong, Hui
    Zhang, Lirong
    Chen, Yupeng
    NATURE METABOLISM, 2020, 2 (08) : 717 - +
  • [35] Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease
    Zeyun Mi
    Yandong Song
    Xinyi Cao
    Yi Lu
    Zhiheng Liu
    Xu Zhu
    Meijuan Geng
    Yongzhan Sun
    Bingxue Lan
    Chaoran He
    Hui Xiong
    Lirong Zhang
    Yupeng Chen
    Nature Metabolism, 2020, 2 : 717 - 731
  • [36] Inhibition of the mTOR pathway by rapamycin reverses renal cystogenesis in polycystic kidney disease models
    Hedgepeth, RC
    Shillingford, JM
    Murcia, NS
    Larson, CH
    Flask, CA
    Flask, CA
    Novick, AC
    Goldfarb, DA
    Low, SH
    Weimbs, T
    JOURNAL OF UROLOGY, 2006, 175 (04): : 178 - 178
  • [37] ANIMAL-MODELS OF POLYCYSTIC KIDNEY-DISEASE
    AZIZ, N
    BIOESSAYS, 1995, 17 (08) : 703 - 712
  • [38] Autosomal dominant polycystic kidney disease: Novel therapeutic options
    Serra A.L.
    Poster D.
    Wüthrich R.P.
    Der Nephrologe, 2010, 5 (5): : 404 - 411
  • [39] Novel therapeutic approaches to autosomal dominant polycystic kidney disease
    Lariviere, Wells B.
    Irazabal, Maria V.
    Torres, Vicente E.
    TRANSLATIONAL RESEARCH, 2015, 165 (04) : 488 - 498
  • [40] Novel targets for the treatment of autosomal dominant polycystic kidney disease
    Belibi, Franck A.
    Edelstein, Charles L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (03) : 315 - 328
12345